Clinical Transplantation

Article	Citations
Issue Information	47
	47
Association between dd‐cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort	41
The optimal immunosuppression management to prevent early rejection after liver transplantation: A systematic review of the literature and expert panel recommendations	41
Issue Information	34
Ultrasound Utilization in Hospitalized Kidney Transplant Recipients: Useful or Overused?	32
Preliminary feasibility of animated video education designed to empower patients’ referral to kidney transplantation	31
Efficacy, Tolerability, and Safety of Glucagon‐Like Peptide 1 Receptor Agonists (GLP1‐RA) in Kidney Transplant Recipients With Diabetes	31
Feasibility of providing web‐based education to patients prior to kidney transplant evaluation	30
Perioperative Bleeding Risk in Lung Transplantation After Previous Cardiothoracic Surgery	30
Restriction of interleukin‐6 alters endothelial cell immunogenicity in an allogenic environment	27
Impact of kidney transplant on post‐operative morbidity and mortality in patients with pre‐operative cardiac dysfunction	26
Persisting dental foci increase the risk for bacterial infections before and after liver transplant	26
Does dialysis modality or duration influence outcomes in simultaneous pancreas‐kidney transplant recipients? Single center experience and review of the literature	24
Transplantation in Iran	24
Beyond Borders: International Immunosuppression Practices in Pediatric Lung Transplantation	22
Increased intrarenal post‐glomerular blood flow is a key condition for the development of calcineurin inhibitor‐induced renal tubular acidosis in kidney transplant recipients	21
Deep vein thrombosis and pulmonary embolism after heart transplantation	21
Toward continuous improvement of Scientific Registry of Transplant Recipients performance reporting: Advances following 2012 consensus conference and future consensus building for 2022 consensus confe	20
Association of body mass index with post‐liver transplant outcomes	18
Mandating COVID‐19 immunization for living organ donors	18
Sociodemographic disparities in sodium‐glucose cotransporter‐2 inhibitor use among US kidney transplant recipients: An observational study of real‐world pharmacy records	18
Factors associated with telemedicine utilization among post‐transplant patients at a university kidney and pancreas transplant center	18
Impact of Share 35 liver transplantation allocation in Australia and New Zealand	18
Contemporary Immunosuppression Management and 1‐Year Outcomes in Dual Organ Heart Transplantation	17

The impact of the distance between patient residency and heart transplant center on outcomes after heart transplantation	17
Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation	17
Diagnosis of Cutaneous Acute Graft‑Versus‑Host Disease Through Circulating Plasma miR‐638, miR‐6511b‐5p, miR‐3613‐5p, miR‐455‐3p, miR‐5787, and miR‐548a‐3p as Prospective Noninvasive Biomarkers Follow	17
Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference	17
Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights	16
Geographic Variation Exists in Heart Transplantation for Status One and Two Patients After the 2018 Heart Allocation Policy Change	16
Issue Information	16
External Validation of a Limited Sampling Strategy for the Estimation of Mycophenolic Acid Exposure Between Different Assay Methods: PETINIA and HPLC Methods	16
Hyperfibrinolysis Detection During Liver Transplantation Using Viscoelastometry	16
Financial impact of donation after circulatory death heart transplantation: A single‐center analysis	16
Successful outcomes with transplanting kidneys from deceased donors with acute kidney injuryon temporary renal replacement therapy	16
Outcomes following heart or bilateral‐lung transplantation from donors who died of drug toxicity in British Columbia, Canada	15
Increased Mortality in Kidney Transplant Recipients During the Delta/Omicron Era of the COVID‐19 Pandemic Despite Widespread Vaccination	15
Coronavirus disease 2019 vaccine in pediatric post‐kidney transplantation	15
Issue Information	15
The effect of intensity of conditioning regimen on the outcome of HSCT in children with sickle cell disease	15
Size‐mismatched transplantation from large donors to small recipients is associated with pancreas graft thrombosis: A retrospective national observational study	15
Decreasing the Risk of Early Sub‐Therapeutic Tacrolimus Troughs on Short‐Term Outcomes in Low‐Moderate Risk Kidney Transplant Recipients Receiving Rabbit Anti‐Thymocyte Globulin Induction	15
	15
Covid‐19 positive donor utilization for heart transplantation: The new frontier for donor pool expansion	14
Fentanyl for the prevention and management of Takotsubo syndrome	14
COVID‐19 in heart transplant recipients during February–August 2020: A systematic review	14
Rabbit antithymocyte globulin dose and early subclinical and clinical rejections in kidney transplantation	14
Perfusion and oxygenation in allografts with transplant renal artery stenosis: Evaluation with functional magnetic resonance imaging	14
High grade urothelial carcinoma in kidney transplant patients with a history of BK viremia – Just a coincidence?	14
Sleep and Respiratory Parameters After Lung Transplantation in Adult Patients With Cystic Fibrosis	14
Impact of SIRPα polymorphism on transplant outcomes in HLA‐identical living donor kidney transplantation	14
A single center Israeli experience in pregnancy post lung transplantation: Feasibility of successful two or more full‐term pregnancies in individual lung transplant recipients	14
Is it safe to expand the indications for split liver transplantation in adults? A single‐center analysis of 155 in‐situ splits	14
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience	14
Potential association between public medical insurance, waitlist mortality, and utilization of living donor liver transplantation: An analysis of the Scientific Registry of Transplant Recipients	14
Blood transfusion of the donor is associated with stage 3 primary graft dysfunction after lung transplantation	13
Seasonal Patterns of Living Kidney Donation in the United States From 1995 to 2019	13
Postoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients	13
Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients	13
Advances and Challenges of Thrombolytic Therapy for Donation After Circulatory Death Organs	13
Accuracy of administrative database estimates of national surgical volume: Solid organ transplantation in the National Inpatient Sample	13
Surgical complications and technical failure of simultaneous pancreas‐kidney transplantation: A 22‐year experience from a single center	13
Effectiveness and safety of once‐daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study	12
A survey of intensive care unit models in cardiothoracic transplantation at high‐volume centers	12
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States	12
Public Acceptance of Living Donor Liver Transplant for Colorectal Liver Metastases: A Web‐Based Survey	12
Effectiveness and safety of glucagon‐like peptide‐1 receptor agonist in a cohort of kidney transplant recipients	12
Outcomes of kidney transplant recipients with ESKD due to plasma cell dyscrasia: A case series	12
Issue Information	12
Early reversal of the lymphocyte‐to‐monocyte ratio after allogeneic‐hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis	12
Diagnosis and predicted outcomes of patients with cystic fibrosis related liver disease considered for lung transplantation	12
Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation	12
Association of Donor Vascular Endothelial Growth Factor Gene Polymorphism With Acute Renal Allograft Rejection	12
Intraoperative hypotension and the risk of acute kidney injury following liver transplantation	12

Worldwide organ allocation systems for pediatric lung transplantation	12
The changing landscape of pediatric lung transplantation	12
Does Weekend Discharge Affect Readmission and Survival in Liver Transplant Patients? Insights From a Cohort Study	12
A report of a prospective randomized trial of extended‐release tacrolimus versus immediate release tacrolimus after liver transplantation with anti‐thymocyte induction in a steroid free protocol	12
Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients	12
	12
Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium	12
Comparison of outcomes in vaccinated versus unvaccinated COVID‐19 kidney transplant recipients, a single center retrospective study—Is the taboo justified?	12
Pulse Wave Velocity in Pediatric Heart Transplant Recipients–A Marker of Vascular Health	12
Transplantation Related Mortality Did Not Show Significant Differences in Patients Aged Above 55 Years With Hematological Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplantation in a	12
Hemodynamic failure and graft dysfunction after lung transplant: A possible clinical continuum with immediate and long‐term consequences	12
Comparing Mid‐Term Outcomes of Donation After Brain Death and Donation After Circulatory Death Orthotopic Heart Transplant Recipients–A Single‐Center Retrospective UK Study	11
Liver Transplant Fast‐Track With an Emphasis on Reduced Delirium: A Multidisciplinary Approach to Reducing Length of Stay	11
Efficacy and safety of total lymphoid irradiation in different chronic lung allograft dysfunction phenotypes	11
Predictors and outcomes of respiratory failure among lung transplant patients with COVID‐19	11
	11
Impact of OPTN policy 3.7D providing waiting time modification for candidates affected by race‐inclusive eGFR calculations: Early results from a single center	11
Immune Checkpoint Inhibitor Use in Kidney Transplant Patients: A National Case Series From Ireland	11
Lung transplantation in the septuagenarian can be successfully performed though long‐term results impacted by diseases of aging	11
Sodium‐glucose co‐transporter 2 inhibitors & glucagon‐like peptide‐1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients	11
Textbook surgical outcome in lung transplantation: Analysis of a US national registry	11
Impact of risk‐stratified mycophenolate dosing in heart transplantation	11
Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First‐Line Continuous Infusion Vasopressor in Kidney Transplant Recipients	11
Perioperative fluid management and outcomes in adult deceased donor liver transplantation – A systematic review of the literature and expert panel recommendations	11
Post‐kidney transplant body mass index trajectories are associated with graft loss and mortality	11
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients	11
Quality of Life in Patients 20–31 Years After Heart Transplantation	11
Galectin‐3 as an independent prognostic factor after heart transplantation	11
	10
Impact of the 2014 kidney allocation system changes on trends in A2/A2B into B kidney transplantation and organ procurement organization reporting of donor subtyping	10
Cystic fibrosis survival outcomes following second lung transplant: The north American experience	10
Successful liver transplantation from deceased donors with active COVID‐19 infections with undetectable SARS‐CoV‐2 in donor liver and aorta	10
Donor rhabdomyolysis, acute kidney injury, and kidney transplant outcomes	10
Multi‐phasic eGFR trajectory during follow up and long‐term graft failure after kidney transplantation	10
In Memoriam—Professor Sir Peter Morris	10
Impact of donation after circulatory death heart transplantation on waitlist outcomes and transplantation activity	10
Posterior reversible encephalopathy syndrome after lung transplantation: Risk factors and management	10
Retransplanting a previously transplanted kidney: A safe strategy in times of organ shortage?	10
How the websites of high‐volume US centers address the risks of living kidney donation	10
Removal of the Black race coefficient from the estimated glomerular filtration equation improves transplant eligibility for Black patients at a single center	10
Impact of induction therapy on cytomegalovirus infection and post‐transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis	10
Outcomes after lung resection in renal transplant patients with pulmonary mucormycosis	10
Heart transplant in a Sars‐CoV‐2 positive recipient: Management protocol of the world's first case	10
Hepatitis C and heart transplantation: An update	10
A modified conditioning regimen based on low‐dose cyclophosphamide and fludarabine for haploidentical hematopoietic stem cell transplant in severe aplastic anemia patients at risk of severe cardiotoxi	10
Can we HALT obesity following lung transplant? A Dietitian‐ and Physiotherapy‐directed pilot intervention	10
Regional Disparities in Kidney Transplant Allocation in Brazil: A Retrospective Cohort Study	9
Successful Kidney Transplantation Despite Therapeutic Anticoagulation—Effective Apixaban Elimination by Hemoadsorption	9
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and	9
Lessons Learned From Extracorporeal Life Support Practice and Outcomes During the COVID‐19 Pandemic	9
Safety of glucose‐6 phosphate dehydrogenase deficient donors in living right lobe liver donation	9
Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients	9
Do outcomes for heart transplantation differ based on donor and recipient race?	9
Exploring Anesthesiology Management of Living Donor Liver Transplantation: Survey From the Society for the Advancement of Transplant Anesthesia and the Korean Society for Transplantation Anesthesiolog	9
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers	9
CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions	9
COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland	9
Impact of UNOS allocation policy changes on utilization and outcomes of patients bridged to heart transplant with intra‐aortic balloon pump	9
A geographic information system dashboard for heart transplantation	9
Assessing the influence of graft loss on 4‐year patient survival after simultaneous pancreas‐kidney transplantation: Kaplan–Meier versus Competing Risk Analysis model	9
Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas After Liver Transplantation	9
Effects of Nighttime Procurement and Transplantation on Outcomes Following Heart Transplantation	9
Does lung procurement and exposure to Perfadex impact heart transplantation outcomes	9
The utility of inpatient rehabilitation in heart transplantation: A review	9
Organ transplant and Covid‐19 vaccination: Considering the ethics of denying transplant to unvaccinated patients	9
Lung transplant airway complications treated with biodegradable airway stents: The Dutch multi‐center experience	9
Factors influencing organ donation in Fujian's Organ Procurement Organization: A retrospective study	8
Cover Image, Volume 37, Issue 7	8
Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme	8
Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation	8
Mismatched perfusion defects on routine ventilation‐perfusion scans after lung transplantation	8
Organ Offer Review Cards: Improving Transparency on the Kidney Transplant Waitlist	8
Heart transplantation in the era of corona virus disease 2019: Impact of the pandemic on donors, recipients and outcome	8
Liver viability using normothermic regional perfusion in uncontrolled donation after circulatory death deserves a multi‐parametric assessment	8
Difference in absolute lymphocyte count among male and female heart transplant recipients	8
Anticoagulation and safety of renal transplant biopsy	8
Utility of Quadratus Lumborum Blocks in Patients Who Undergo Liver Transplant: A Single‐Center Retrospective Study	8
Cover Image, Volume 38, Issue 8	8
Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy	8
Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine	8

Impact of Ex Vivo Lung Perfusion on Inpatient Cost: A Propensity Score‐Matched Analysis of the US Nationwide Healthcare Cost and Utilization Project Database	8
A viewpoint describing the American Society of Transplantation rationale to conduct a comprehensive patient survey assessing unmet immunosuppressive therapy needs	8
Social network interventions to reduce race disparities in living kidney donation: Design and rationale of the friends and family of kidney transplant patients study (FFKTPS)	8
Cardio‐Renal‐Metabolic Outcomes Associated With the Use of GLP‐1 Receptor Agonists After Heart Transplantation	8
A2/A2B to B kidney transplantation outcomes: A single center 7‐year experience	8
Association of physical activity with fractures in kidney transplant recipients: A Korean nationwide cohort study	8
Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients	8
Factors associated with early postoperative exercise tolerance after living‐donor liver transplantation	8
Absence of hemoglobin increase is associated with reduced graft survival after kidney transplantation	8
Review–Long‐Term Care of Kidney Transplant Patients	8
Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation	8
Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation	8
High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients	8
Early post‐transplant leukopenia in heart transplant recipients and its impact on outcomes	8
Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post‐transplant viremia	8
Assessment of Posttransplant Bacteremia Caused by Extended‐Spectrum Beta‐Lactamase–Producing Gram‐Negative Bacteria Among Kidney Transplant Recipients	8
The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults	8
mTORi‐based immunosuppression reduces HCC recurrence at the expense of increased adverse side effects: A systematic review and meta‐analysis	8
Prolonged cold ischemia and kidney donation after cardiac death	8
Do pretransplant C‐peptide levels predict outcomes following simultaneous pancreas‐kidney transplantation? A matched case‐control study	8
Early post‐operative lactate increase following kidney transplant is associated with delayed graft function: A retrospective cohort study	7
	7
Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes	7
“You don't know what you don't know”: A qualitative study of informational needs of patients, family members, and living donors to inform transplant system metrics	7
Independent Risk Factors and Economic Burden Associated With Delayed Extubation Following Pediatric Liver Transplantation	7
Blood salvage and autotransfusion during orthotopic liver transplantation for hepatocellular carcinoma: A systematic review and meta‐analysis	7
Does bortezomib influence pre‐transplant desensitization therapy or benefit post‐heart transplant outcomes for highly sensitized patients?	7
Examining the transplant case composition of early‐career transplant surgeons	7
Telemedicine based remote monitoring after liver transplantation: Feasible in a select group and a more stringent control of immunosuppression	7
Aggressive pursuit and utilization of non‐ideal donor lungs does not compromise post‐lung transplant survival	7
Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes	7
Impact of prior COVID‐19 infection on allogeneic hematopoietic stem cell transplantation outcomes	7
Myocardial injury biomarkers at point of care for early identification of primary graft dysfunction after heart transplantation	7
Association of HLA Mismatch With Adverse Cardiovascular Events Following Lung Transplantation: A Single‐Center Study	7
Real world experience with Maribavir for the treatment of cytomegalovirus in solid organ transplant recipients	7
Basiliximab induction versus no induction in adult heart transplantation	7
Lung transplantation in primary pulmonary arterial hypertension and pulmonary venous hypertension	7
Lack of Association Between Donor‐Derived Cell‐Free DNA and Cardiac Allograft Vasculopathy	7
Expression of fibrosis‐related genes in liver allografts: Association with histology and long‐term outcome after pediatric liver transplantation	7
When is the optimal time to discharge patients after liver transplantation with respect to short‐term outcomes? A systematic review of the literature and expert panel recommendations	7
	7
Dual‐Energy X‐Ray Absorptiometry‐Derived Advanced Hip Analysis and the Trabecular Bone Score Are Associated With the Diagnosis of Fracture Following Kidney and Simultaneous Pancreas‐Kidney Transplanta	7
Enhanced Artificial Intelligence Methods for Liver Steatosis Assessment Using Machine Learning and Color Image Processing: Liver Color Project	7
Association between artificial nutrition in brain dead donors and early allograft function in liver transplant recipients: an observational study	7
Outcomes of living liver donor candidate evaluations in the Living Donor Collective pilot registry	7
Interaction between ischemic time and donor age under the new donor heart allocation system: Effect on post‐transplant survival	7
Paradoxical outcome of heart transplantation associated with institutional case volume	7
Disparities in telemedicine utilization among kidney transplant patients during the COVID‐19 pandemic: Barriers and opportunities	7
Immune outcomes of lung transplant recipients with different cytochrome P450 3A5 phenotypes after discontinuation of voriconazole antifungal prophylaxis	6
Incidence and Risk Factors for Stroke After Combined Heart‐Kidney and Heart‐Liver Transplantation	6
	6
Risk and Reward: Nationwide Analysis of Cardiac Transplant Center Variation in Organ Travel Distance and the Effects on Outcomes	6
Adult liver transplant anesthesiology practice patterns and resource utilization in the United States: Survey results from the society for the advancement of transplant anesthesia	6
Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients	6
Long‐term outcomes after heart transplantation using ex vivo allograft perfusion in standard risk donors: A single‐center experience	6
Benefits of both physical assessment and electronic health record review to assess frailty prior to heart transplant	6
Thoracic transplantation during the COVID‐19 pandemic	6
Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study	6
Intraoperative fluid management and kidney transplantation outcomes: A retrospective cohort study	6
Phenytoin to expedite sirolimus and tacrolimus elimination	6
Hypoalbuminemia is a risk factor for invasive fungal infections and poor outcomes in infected kidney transplant recipients	6
Impact of the heart transplant allocation policy change on inpatient cost of index hospitalization	6
Evaluating a unique enhanced recovery protocol in laparoscopic donor nephrectomy: A single center experience	6
Histological evaluation of ischemic alterations in donors after cardiac death: A useful tool to predict post‐transplant renal function	6
Safety of laparoscopic repair of incisional hernias in liver transplant recipients	6
Anticoagulation and Antiplatelet Regimen in Cardiac Transplant. Clinical Characteristics, Outcomes, and Blood Product Transfusion	6
Issue Information	6
Medical Distrust Among Kidney Transplant Candidates	6
Poor utilization of deceased donor pancreata in the United States: Time for action	6
What is the optimal prophylaxis against postoperative deep vein thrombosis in the living donor to avoid complications and enhance recovery? – A systematic review of the literature and expert panel rec	6
Issue Information	6
Transplantation of kidneys after normothermic perfusion: A single center experience	6
Donor's long‐term quality of life following living‐donor lobar lung transplantation	6
Survival in Patients With Evidence of Pulmonary Thromboembolism on Ventilation‐Perfusion SPECT 12 Weeks After Double Lung Transplantation: A Retrospective Cohort Study	6
Variation Across Organ Procurement Organizations in Deceased‐Donor Kidney Offer Notification Practices	6
Factors associated with a positive phosphatidylethanol test during liver transplantation evaluation	6
Donor hypernatremia is associated with increased mortality after heart transplantation: A retrospective study	6
Genetic Polymorphisms of Cytotoxic T‐Lymphocyte Antigen 4 (CTLA‐4) and clinical outcomes post‐allogeneic hematopoietic stem cell transplantation: A systematic review and meta‐analysis	6
Impact of cardiac dysfunction on morbidity and mortality in liver transplant candidates	6
Comparing outcomes in right versus left kidney transplantation: A systematic review and meta‐analysis	6
Utilization and discard of organs from donors with COVID‐19 in the United States	6
Critical interactions between race and the highly granular area deprivation index in liver transplant evaluation	6
Oxalate Nephropathy After Kidney Transplantation: Risk Factors and Outcomes of Two Phenotypes	6
Type A Aortic Dissection Following Abdominal Solid Organ Transplantation: Population‐Level Outcomes in the United States	6
Donor heart dysfunction and graft survival in liver and kidney transplants—A register‐based study from Sweden	6
The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage	6
Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience	6
Successful Multiorgan Transplantation in Highly Sensitized Patients With Positive Crossmatch Donor	6
Veno‐arterial ECMO ventricular assistance as a direct bridge to heart transplant: A single center experience in a low‐middle income country	6
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients	6
Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients	6
Programmed cell death ligand 1 expression associated with subtypes of post‐transplant lymphoproliferative disorder among pediatric kidney transplant recipients	6
Role of time from transplantation to biopsy in histologic ABMR: A single center report	6
Preoperative echocardiography as a prognostic tool for liver transplant in patients with hypertrophic cardiomyopathy	6
Postoperative cognitive dysfunction in heart transplantation recipients	6